Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Large-Scale Proteomics Analysis of Human Ovarian Cancer for Biomarkers

In English

Författare

  • S Bengtsson
  • Morten Krogh
  • C Al-Khalili Szigyarto
  • M Uhlen
  • K Schedvins
  • C Silfversward
  • S Linder
  • G Auer
  • A Alaiya
  • Peter James

Summary, in English

Ovarian cancer is usually found at a late stage when the prognosis is often bad. Relative survival rates decrease with tumor stage or grade, and the 5-year survival rate for women with carcinoma is only 38%. Thus, there is a great need to find biomarkers that can be used to carry out routine screening, especially in high-risk patient groups. Here, we present a large-scale study of 64 tissue samples taken from patients at all stages and show that we can identify statistically valid markers using nonsupervised methods that distinguish between normal, benign, borderline, and malignant tissue. We have identified 217 of the significantly changing protein spots. We are expressing and raising antibodies to 35 of these. Currently, we have validated 5 of these antibodies for use in immunohistochemical analysis using tissue microarrays of healthy and diseased ovarian, as well as other, human tissues.

Publiceringsår

2007

Språk

Engelska

Sidor

1440-1450

Publikation/Tidskrift/Serie

Journal of Proteome Research

Volym

6

Issue

4

Dokumenttyp

Artikel i tidskrift

Förlag

The American Chemical Society (ACS)

Ämne

  • Immunology in the medical area
  • Biophysics

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1535-3893